Sarah Hein

Sarah Hein

Nov
16

mRNA COVID vaccines pull ahead, and I have a favorite

3 min read
Nov
05

Investment gaps in cancer biotech (and why you should bet on Texas)

7 min read
Jun
12

Bispecific therapeutics are about to make a big comeback

6 min read
Jun
04

Better, faster, cheaper drug development is here to stay

2 min read
May
20

How Moderna is winning the race to a COVID-19 vaccine

5 min read